The Journal of Thoracic and Cardiovascular Surgery
Volume 136, Issue 5 , Pages 1178-1186 , November 2008

Transgenic model of cardiac rhabdomyosarcoma formation

  • Christiane Köbbert, PhD

      Affiliations

    • Department of Cardiology and Angiology, Hospital of the University of Münster, Münster, Germany
    • Leibniz Institute for Arteriosclerosis Research, the University of Münster, Münster, Germany
  • ,
  • Christa Möllmann

      Affiliations

    • Department of Cardiology and Angiology, Hospital of the University of Münster, Münster, Germany
    • Leibniz Institute for Arteriosclerosis Research, the University of Münster, Münster, Germany
  • ,
  • Michael Schäfers, MD

      Affiliations

    • Department of Nuclear Medicine, Hospital of the University of Münster, Münster, Germany
  • ,
  • Sven Hermann, MD

      Affiliations

    • Department of Nuclear Medicine, Hospital of the University of Münster, Münster, Germany
  • ,
  • Hideo A. Baba, MD

      Affiliations

    • Institute of Pathology, Hospital of the University of Duisburg-Essen, Essen, Germany
  • ,
  • Andreas Hoffmeier, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Hospital of the University of Münster, Münster, Germany
  • ,
  • Günter Breithardt, MD

      Affiliations

    • Department of Cardiology and Angiology, Hospital of the University of Münster, Münster, Germany
    • Leibniz Institute for Arteriosclerosis Research, the University of Münster, Münster, Germany
  • ,
  • Hans H. Scheld, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Hospital of the University of Münster, Münster, Germany
  • ,
  • Gabriele Weissen–Plenz, PhD

      Affiliations

    • Department of Cardiology and Angiology, Hospital of the University of Münster, Münster, Germany
    • Leibniz Institute for Arteriosclerosis Research, the University of Münster, Münster, Germany
    • Department of Thoracic and Cardiovascular Surgery, Hospital of the University of Münster, Münster, Germany
  • ,
  • Jürgen R. Sindermann, MD

      Affiliations

    • Department of Cardiology and Angiology, Hospital of the University of Münster, Münster, Germany
    • Leibniz Institute for Arteriosclerosis Research, the University of Münster, Münster, Germany
    • Department of Thoracic and Cardiovascular Surgery, Hospital of the University of Münster, Münster, Germany
    • Corresponding Author InformationAddress for reprints: Jürgen R. Sindermann, MD, Department of Thoracic and Cardiovascular Surgery, Hospital of the University of Münster, Albert-Schweitzer-Strasse 33, 48149 Münster, Germany.

Received 16 December 2007 ,Revised 18 February 2008 ,Accepted 20 April 2008.

References 

  1. McAllister HA, Fenoglio JJ. Tumors of the cardiovascular system. In: Atlas of tumor pathology. Washington, DC: Armed Forces Institute of Pathology; 1978;p. 1–141
  2. Zietz C, Rossle M, Haas C, Sendelhofert A, Hirschmann A, Sturzl M, et al. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas. Am J Pathol. 1998;153:1425–1433
  3. Iyengar V, Lineberger AS, Kerman S, Burton NA. Synovial sarcoma of the heart. Correlation with cytogenetic findings. Arch Pathol Lab Med. 1995;119:1080–1082
  4. Hazelbag HM, Szuhai K, Tanke HJ, Rosenberg C, Hogendoorn PC. Primary synovial sarcoma of the heart: a cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH of a case with a complex karyotype. Mod Pathol. 2004;17:1434–1439
  5. Palmer JL, Masui S, Pritchard S, Kalousek DK, Sorensen PH. Cytogenetic and molecular genetic analysis of a pediatric pleomorphic sarcoma reveals similarities to adult malignant fibrous histiocytoma. Cancer Genet Cytogenet. 1997;95:141–147
  6. Zu Y, Perle MA, Yan Z, Liu J, Kumar A, Waisman J. Chromosomal abnormalities and p53 gene mutation in a cardiac angiosarcoma. Appl Immunohistochem Mol Morphol. 2001;9:24–28
  7. Hong HH, Devereux TR, Melnick RL, Moomaw CR, Boorman GA, Sills RC. Mutations of ras protooncogenes and p53 tumor suppressor gene in cardiac hemangiosarcomas from B6C3F1 mice exposed to 1,3-butadiene for 2 years. Toxicol Pathol. 2000;28:529–534
  8. Naka N, Tomita Y, Nakanishi H, Araki N, Hongyo T, Ochi T, et al. Mutations of p53 tumor-suppressor gene in angiosarcoma. Int J Cancer. 1997;71:952–955
  9. Garcia JM, Gonzalez R, Silva JM, Dominguez G, Vegazo IS, Gamallo C, et al. Mutational status of K-ras and TP53 genes in primary sarcomas of the heart. Br J Cancer. 2000;82:1183–1185
  10. Gannon JV, Lane DP. p53 and DNA polymerase alpha compete for binding to SV40 T antigen. Nature. 1987;329:456–458
  11. DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell. 1988;54:275–283
  12. Dyson N, Buchkovich K, Whyte P, Harlow E. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell. 1989;58:249–255
  13. Wolf DA, Hermeking H, Albert T, Herzinger T, Kind P, Eick D. A complex between E2F and the pRb-related protein p130 is specifically targeted by the simian virus 40 large T antigen during cell transformation. Oncogene. 1995;10:2067–2078
  14. Steinhelper ME, Field LJ. Cardiac tumors and dysrhythmias in transgenic mice. Toxicol Pathol. 1990;18:464–469
  15. Steinhelper ME, Lanson NA, Dresdner KP, Delcarpio JB, Wit AL, Claycomb WC, et al. Proliferation in vivo and in culture of differentiated adult atrial cardiomyocytes from transgenic mice. Am J Physiol Heart Circ Physiol. 1990;259:H1826–H1834
  16. Katz EB, Steinhelper ME, Delcarpio JB, Daud AI, Claycomb WC, Field LJ. Cardiomyocyte proliferation in mice expressing alpha-cardiac myosin heavy chain-SV40 T-antigen transgenes. Am J Physiol Heart Circ Physiol. 1992;262:H1867–H1876
  17. De Leon JR, Federoff HJ, Dickson DW, Vikstrom KL, Fishman GI. Cardiac and skeletal myopathy in beta myosin heavy-chain simian virus 40 tsA58 transgenic mice. Proc Natl Acad Sci U S A. 1994;91:519–523
  18. Li L, Miano JM, Cserjesi P, Olson EN. SM22α, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ Res. 1996;78:188–195
  19. Li L, Miano JM, Mercer B, Olson EN. Expression of the SM22α, promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol. 1996;132:849–859
  20. Fiers W, Contreras R, Haegeman G, Rogiers R, Van de Voorde A, Van Heuverswyn H, et al. Complete nucleotide sequence of SV40 DNA. Nature. 1978;273:113–120
  21. Kim SH, Roth KA, Coopersmith CM, Pipas JM, Gordon JI. Expression of wild-type and mutant simian virus 40 large tumor antigens in villus-associated enterocytes of transgenic mice. Proc Natl Acad Sci U S A. 1994;91:6914–6918
  22. Li M, Hu J, Heermeier K, Henninghausen L, Furth PA. Expression of a viral oncoprotein during mammary gland development alters cell fate and function: induction of p53-independent apoptosis is followed by impaired milk protein production in surviving cells. Cell Growth Differ. 1996;7:3–11
  23. Schäfers KP, Reader AJ, Kriens M, Knoess C, Schober O, Schäfers M. Performance evaluation of the 32-module quadHIDAC small-animal PET scanner. J Nucl Med. 2005;46:996–1004
  24. Vujin B, Benc D, Srdic S, Bikicki M, Vuckovic D, Dodic S. Rhabdomyosarcoma of the heart. Herz. 2006;31:798–800
  25. Hoffmeier A, Etz C, Schmid C, Debus V, Kehl HG, Özgün M, et al. Cardiac transplantation for giant sarcoma of the left ventricle. Circulation. 2005;112:e247–e249
  26. Tavil Y, Turkoglu S, Tacoy G, Cemeri M. Huge biatrial cardiac rhabdomyosarcoma resulting in bilateral atrioventricular valve obstruction. Cardiovasc Pathol. 2006;15:354–355
  27. Engelen M, Bruch C, Hoffmeier A, Kersting C, Stypmann J. Primary left atrial angiosarcoma mimicking severe mitral valve stenosis. Heart. 2005;91:e27
  28. Kosuga T, Fukunaga S, Kawara T, Yokose S, Akasu K, Tayama E, et al. Surgery for primary cardiac tumors. Clinical experience and surgical results in 60 patients. J Cardiovasc Surg (Torino). 2002;43:581–587
  29. Thoma-de-Montpreville V, Nottin R, Dulmet E, Serraf A. Heart tumors in children and adults: clinicopathological study of 59 patients from a surgical center. Cardiovasc Pathol. 2007;16:22–28
  30. Gregson RL. A metastasizing cardiac rhabdomyosarcoma in a CD 1 strain mouse. J Comp Pathol. 1984;94:477–480
  31. Kim KK, Soonpaa MH, Daud AI, Koh GY, Kim JS, Field LJ. Tumor suppressor gene expression during normal and pathologic myocardial growth. J Biol Chem. 1994;269:22607–22613
  32. Sindermann JR, Babij P, Klink JC, Köbbert C, Plenz G, Ebbing J, et al. Smooth muscle-specific expression of SV40 large TAg induces SMC proliferation causing adaptive arterial remodeling. Am J Physiol Heart Circ Physiol. 2002;283:H2714–H2724
  33. Sindermann JR, March KL. Balancing luminal size and smooth muscle proliferation—a key control point in atherosclerosis and arteriogenesis. EXS. 2005;94:193–205
  34. Moll R, Holzhausen HJ, Mennel HD, Kuhn C, Baumann R, Taege C, et al. The cardiac isoform of alpha-actin in regenerating and atrophic skeletal muscle, myopathies and rhabdomyomatous tumors: an immunohistochemical study using monoclonal antibodies. Virchows Arch. 2006;449:175–191
  35. Dias P, Parham DM, Shapiro DN, Tapscott SJ, Houghton PJ. Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility. Cancer Res. 1992;52:6431–6439
  36. Wysoczynski M, Miekus K, Jankowski K, Wanzeck J, Bertolone S, Janowska-Wieczorek A, et al. Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas. Cancer Res. 2007;67:2131–2140
  37. Shor AC, Keschman EA, Lee FY, Muro-Cacho C, Letson GD, Trent JC, et al. Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival. Cancer Res. 2007;67:2800–2808

 This work has been supported in part by an “Innovative Medical Research” grant of the University of Münster.

PII: S0022-5223(08)01056-8

doi: 10.1016/j.jtcvs.2008.04.022

The Journal of Thoracic and Cardiovascular Surgery
Volume 136, Issue 5 , Pages 1178-1186 , November 2008